Viktor H Koelzer

Viktor H Koelzer

UNVERIFIED PROFILE

Are you Viktor H Koelzer?   Register this Author

Register author
Viktor H Koelzer

Viktor H Koelzer

Publications by authors named "Viktor H Koelzer"

Are you Viktor H Koelzer?   Register this Author

48Publications

1446Reads

47Profile Views

Precision immunoprofiling by image analysis and artificial intelligence.

Virchows Arch 2019 Apr 23;474(4):511-522. Epub 2018 Nov 23.

Institute of Pathology, Cantonal Hospital Baselland, Mühlemattstrasse 11, CH-4410, Liestal, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-018-2485-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447694PMC
April 2019

Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients.

Clin Colorectal Cancer 2019 03 21;18(1):e20-e38. Epub 2018 Sep 21.

Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028183008
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2018.09.007DOI Listing
March 2019

Digital image analysis improves precision of PD-L1 scoring in cutaneous melanoma.

Histopathology 2018 Sep 5;73(3):397-406. Epub 2018 Jun 5.

Cantonal Hospital Baselland, Institute of Pathology, Liestal, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13528DOI Listing
September 2018

Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.

Cancer Immunol Immunother 2018 01 11;67(1):39-45. Epub 2017 Sep 11.

Department of Dermatology/Allergology, Cantonal Hospital St. Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2061-4DOI Listing
January 2018

The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors.

Oncoimmunology 2018 26;7(2):e1386362. Epub 2017 Oct 26.

Laboratory of Cancer Immunology, Department of Biomedicine, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1386362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749666PMC
October 2017

Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.

Histopathology 2017 Jun 2;70(7):1044-1051. Epub 2017 Mar 2.

Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13164DOI Listing
June 2017

DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive.

Virchows Arch 2017 Mar 27;470(3):341-346. Epub 2017 Jan 27.

Institute of Pathology, University of Bern, Murtenstrasse 31, Room L310, CH-3008, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2071-9DOI Listing
March 2017

Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer.

Oncoimmunology 2017 6;6(4):e1288330. Epub 2017 Feb 6.

Translational Research Unit (TRU), Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1288330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414871PMC
February 2017

Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome.

Front Oncol 2016 29;6:252. Epub 2016 Nov 29.

Cantonal Hospital Baselland, Institute of Pathology , Liestal , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2016.00252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126084PMC
November 2016

Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy.

J Immunother Cancer 2016 16;4:47. Epub 2016 Aug 16.

Cantonal Hospital Baselland, Institute of Pathology, Mühlemattstrasse 11, CH-4410 Liestal, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0151-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986338PMC
August 2016

Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.

Hum Pathol 2016 06 10;52:1-8. Epub 2016 Feb 10.

Institute of Pathology, University of Bern, 3010 Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.01.016DOI Listing
June 2016

Tumor budding in colorectal cancer--ready for diagnostic practice?

Hum Pathol 2016 Jan 3;47(1):4-19. Epub 2015 Sep 3.

Clinical Pathology Division, Institute of Pathology, University of Bern, CH-3010 Bern, Switzerland; Translational Research Unit, Institute of Pathology, University of Bern, CH-3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177150031
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2015.08.007DOI Listing
January 2016

Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

Cancer Res 2015 Nov 2;75(21):4483-93. Epub 2015 Oct 2.

Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany. Department of Medicine, University of Fribourg, Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3499DOI Listing
November 2015

Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome.

Transl Res 2015 Aug 4;166(2):207-17. Epub 2015 Mar 4.

Translational Research Unit (TRU), Institute of Pathology, University of Bern, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2015.02.008DOI Listing
August 2015

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.

J Transl Med 2015 Aug 27;13:279. Epub 2015 Aug 27.

Translational Research Unit (TRU), Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-015-0647-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551690PMC
August 2015

Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.

Virchows Arch 2015 May 21;466(5):485-93. Epub 2015 Feb 21.

Translational Research Unit (TRU), Institute of Pathology, University of Bern, Murtenstr. 31, CH-3010, Bern, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-015-1740-9DOI Listing
May 2015

Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.

Histopathology 2015 Apr 23;66(5):715-25. Epub 2014 Dec 23.

Department of Clinical Pathology, Institute of Pathology, University of Bern, Bern, Switzerland; Translational Research Unit, Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12603DOI Listing
April 2015

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.

BMC Cancer 2015 Mar 21;15:160. Epub 2015 Mar 21.

Department of Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Strasse 10, D-13125, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1150-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371627PMC
March 2015

A modular approach to suppression assays: TLR ligands, conditioned medium, and viral infection.

Methods Mol Biol 2014 ;1169:107-20

Clinical Pathology Division and Translational Research Unit, Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-0882-0_11DOI Listing
February 2015

Tumor budding in upper gastrointestinal carcinomas.

Front Oncol 2014 14;4:216. Epub 2014 Aug 14.

Clinical Pathology Division, Institute of Pathology, University of Bern , Bern , Switzerland ; Translational Research Unit, Institute of Pathology, University of Bern , Bern , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132482PMC
September 2014

A simple Baker's cyst? Tocilizumab remits paraneoplastic signs and controls growth of IL-6-producing angiomatoid malignant fibrous histiocytoma.

Rheumatology (Oxford) 2014 Jul 5;53(7):1350-2. Epub 2014 Feb 5.

Department of Rheumatology, Clinical Immunology and Allergology, Institute of Radiology, University Hospital and University of Bern, Institute of Pathology, University of Bern, Bern and Laboratory for Immunology and Clinical Allergology, University Hospital Geneva, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket452DOI Listing
July 2014

The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.

Front Oncol 2014 18;4:29. Epub 2014 Feb 18.

Clinical Pathology Division and Translational Research Unit, Institute of Pathology, University of Bern , Bern , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927120PMC
June 2014

Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.

Int J Cancer 2014 May 13;134(10):2342-51. Epub 2013 Nov 13.

Department of Clinical Pathology, Institute of Pathology, University of Bern, Bern, Switzerland; Translational Research Unit, Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28564DOI Listing
May 2014

The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.

Histopathology 2014 Mar 28;64(4):577-84. Epub 2013 Dec 28.

Clinical Pathology Division, Institute of Pathology, University of Bern, Bern, Switzerland; Translational Research Unit, Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12294DOI Listing
March 2014

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer.

Front Oncol 2013 11;3:265. Epub 2013 Oct 11.

Department of Clinical Pathology, Institute of Pathology, University of Bern , Bern , Switzerland ; Translational Research Unit, Institute of Pathology, University of Bern , Bern , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795344PMC
October 2013

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.

Hum Pathol 2013 May 15;44(5):697-705. Epub 2012 Nov 15.

Institute of Diagnostic Histology and Cytology Aarau, CH-5000 Aarau, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.07.026DOI Listing
May 2013

CD103 is a hallmark of tumor-infiltrating regulatory T cells.

Int J Cancer 2011 Nov 1;129(10):2417-26. Epub 2011 Apr 1.

Center of Integrated Protein Science Munich, Division of Clinical Pharmacology, Ziemssenstrasse 1, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25902DOI Listing
November 2011

Immunostimulatory RNA blocks suppression by regulatory T cells.

J Immunol 2010 Jan 4;184(2):939-46. Epub 2009 Dec 4.

Division of Clinical Pharmacology, Center of Integrated Protein Science Munich, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0901245DOI Listing
January 2010

Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.

Cancer Immunol Immunother 2009 Jun 25;58(6):901-13. Epub 2008 Oct 25.

Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig-Maximilian University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0606-2DOI Listing
June 2009